🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is explore the antibody and cell mediated immune ...
Status
Completed
Location
Azienda Ospedaliera Universtaria Senese
Start Date
2009-12
Trial ID
NCT01079273
Treatments Being Tested
The purpose of this Phase II follow-up study (to study 810501) is to assess...
Status
Completed
Location
University Hospital, Department of Clinical Pharmacology, General Hospital Vienna
Start Date
2007-09
Trial ID
NCT00530660
Treatments Being Tested
The primary purpose of this study is to demonstrate the efficacy of an inve...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00566345
The present study will evaluate clinical efficacy, safety, tolerability and...
Status
Completed
Location
Site 14
Start Date
2007-10
Trial ID
NCT00630331
Treatments Being Tested
The purpose of this study is to compare immunogenicity and safety of ASP737...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01767896
Treatments Being Tested
The objectives of this Phase I/II study are to assess the safety and immuno...
Status
Completed
Location
University of Hong Kong, Queen Mary Hospital
Start Date
2007-07
Trial ID
NCT00517517
The purpose of this study is to describe the immunogenicity and safety of t...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT02344134
Treatments Being Tested
Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy childre...
Status
Completed
Location
320, Novartis Investigational Site
Start Date
2013-05
Trial ID
NCT01857206
Treatments Being Tested
This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...
Status
Completed
Location
AMR Tempe
Start Date
2022-08-25
Trial ID
NCT05501561
Treatments Being Tested
Immunogenicity and safety of a cell-derived influenza vaccine in adults age...
Status
Completed
Location
Site Reference ID/Investigator# 45690
Start Date
2009-05
Trial ID
NCT00889889
Treatments Being Tested